Shares of AbbVie Inc. ABBV rose 1.79% to $200.88 Thursday, on what proved to be an all-around poor trading session for the ...

Researchers from Analysis Group, a global leader in health economics and outcomes research (HEOR), have co-developed a new framework that leverages findings from clinical trials and real-world ...

Pay for college and retirement with a UGMA custodial account and Dividend Growth Investing. Learn why starting early can ...

AbbVie has launched its Produodopa therapy for ... and last year the FDA rejected the drug with a request for more data. GlobalData analyst Christie Wong said Produodopa’s nearest rival at ...

In addition to the Official Singles and Albums Chart, did you know the Official Charts Company compiles 50+ charts every week, spanning different genres and formats? Explore them all here.